# Nasal Fentanyl for Chronic Cancer Pain

> **NCT01906073** · PHASE3 · WITHDRAWN · sponsor: **Norwegian University of Science and Technology**

## Conditions studied

- Cancer
- Pain

## Interventions

- **DRUG:** intranasal fentanyl spray
- **DRUG:** slow release morphine

## Key facts

- **NCT ID:** NCT01906073
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-01
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2020-12-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01906073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01906073, "Nasal Fentanyl for Chronic Cancer Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01906073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*